TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33591141

Group type: EXPERIMENTAL
Intervention: SA with morphine 0.1 mg (SA0.1)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: SA with morphine 0.2 mg (SA0.2)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block with dexamethasone 4 mg + levobupivacaine 0.375% 20 mL (FICB20)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block with dexamethasone 4 mg + levobupivacaine 0.375% 30 mL (FICB30)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Lateral femoral cutaneous nerve block with levobupivacaine 0.25% 5 mL (LFCNB)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: FICB20 + LFCNB
Number of subjects: 510

Group type: COMPARATOR
Intervention: Standardized analgesia (intravenous metamizole magnesium, dexketoprofen, paracetamol, morphine, regional rescue)
Number of subjects: 510
Study: 36183378

Group type: EXPERIMENTAL
Intervention: Long-pulsed alexandrite laser (LPAL) plus low-fluence Nd:YAG
Number of subjects: 27

Group type: COMPARATOR
Intervention: Pulsed-dye laser (PDL)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Comparison of LPAL and PDL
Number of subjects: 27
Study: 33731314

Group type: EXPERIMENTAL
Intervention: Active Theta-burst Stimulation (TBS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham Theta-burst Stimulation (TBS)
Number of subjects: 20
Study: 32858301

Group type: EXPERIMENTAL
Intervention: Intimate partner violence educational intervention based on World Health Organization guidelines
Number of subjects: 104
Study: 36349772

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model for cardiovascular events
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: External validation of the nomogram
Number of subjects: 1138
Study: 33387220

Group type: EXPERIMENTAL
Intervention: Filmed research-based drama (Fit for Dialysis) + 16-week exercise program
Number of subjects: 19

Group type: COMPARATOR
Intervention: 16-week exercise program (Control)
Number of subjects: 19
Study: 32273234

Group type: EXPERIMENTAL
Intervention: Docetaxel chemotherapy
Number of subjects: 1050
Study: 34475035

Group type: EXPERIMENTAL
Intervention: Highly myopic eyes
Number of subjects: 175

Group type: COMPARATOR
Intervention: Non-highly myopic eyes
Number of subjects: 175
Study: 32974672

Group type: EXPERIMENTAL
Intervention: IVM (In-vitro maturation)
Number of subjects: 546

Group type: COMPARATOR
Intervention: IVF (In-vitro fertilization)
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: IVM
Number of subjects: 546

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 546
Study: 35343658

Group type: EXPERIMENTAL
Intervention: Humidified warm CO2 insufflation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dry cold CO2 insufflation
Number of subjects: 40
Study: 34555516

Group type: EXPERIMENTAL
Intervention: Mindful awareness
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Willingness
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Values
Number of subjects: 288
Study: 32771596

Group type: EXPERIMENTAL
Intervention: Mesh removal with analysis of mesh-tissue explants and standardized questionnaires including VAS pelvic pain scores.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonresponders to mesh removal treatment.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pathway analysis of tissue samples.
Number of subjects: 30
Study: 34964149

Group type: EXPERIMENTAL
Intervention: 16 mg galantamine (acute administration)
Number of subjects: 50
Study: 35725017

Group type: EXPERIMENTAL
Intervention: Postpartum diabetes screening (2-hour oral glucose tolerance test within 4-12 weeks postpartum)
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Postpartum diabetes screening
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Elevated risk for type 2 diabetes
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Perinatal depression
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Preterm delivery
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Parity ≥2 children
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Less than college education
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Chinese Americans
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Routine postpartum visit attendance
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Healthcare provider advice about screening
Number of subjects: 1642
Study: 34266927

Group type: EXPERIMENTAL
Intervention: Esophageal temperature probe placed at the time of surgery
Number of subjects: 44

Group type: COMPARATOR
Intervention: No esophageal temperature probe placed
Number of subjects: 44
Study: 34975007

Group type: EXPERIMENTAL
Intervention: Group A (Severity Score ≥ 5)
Number of subjects: 0
Study: 32320465

Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF low-dose (LD; 5 × 10^10 vector particles)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF high-dose (HD; 1 × 10^11 vector particles)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 35181515

Group type: EXPERIMENTAL
Intervention: PediGuard device (impedancemetry-guided pedicle sighting)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Free-hand sighting (control group)
Number of subjects: 16
Study: 33924952

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted eicosapentaenoic acid levels
Number of subjects: 337129

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted dihomo-gamma-linolenic acid levels
Number of subjects: 337129

Group type: EXPERIMENTAL
Intervention: Higher allele scores for linoleic acid levels
Number of subjects: 337129

Group type: EXPERIMENTAL
Intervention: Higher linoleic acid levels (summary-level MR)
Number of subjects: 337129

Group type: EXPERIMENTAL
Intervention: Higher arachidonic acid levels
Number of subjects: 337129
Study: 35781888

Group type: EXPERIMENTAL
Intervention: 3-day protocol of systemic antibiotics (amoxicillin and metronidazole) 500mg 3-times-daily for 3 days, followed by placebo 3-times-daily for 4 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: 7-day protocol of systemic antibiotics (amoxicillin and metronidazole) 500mg 3-times-daily for 7 days
Number of subjects: 50
Study: 33176232

Group type: EXPERIMENTAL
Intervention: Trastuzumab combined with taxanes (eBC)
Number of subjects: 21119

Group type: EXPERIMENTAL
Intervention: Pertuzumab (first-line therapy)
Number of subjects: 21119

Group type: COMPARATOR
Intervention: Trastuzumab–taxane (first-line therapy)
Number of subjects: 21119

Group type: EXPERIMENTAL
Intervention: T-DM1 (second-line treatment)
Number of subjects: 21119

Group type: EXPERIMENTAL
Intervention: First-line treatment for mBC
Number of subjects: 21119

Group type: EXPERIMENTAL
Intervention: Second-line treatment for mBC
Number of subjects: 21119

Group type: EXPERIMENTAL
Intervention: Third-line treatment for mBC
Number of subjects: 21119
Study: 36079871

Group type: EXPERIMENTAL
Intervention: Nutritional intervention based on the Mediterranean diet
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 29
Study: 33171419

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Surgical treatment (hysterectomy, myomectomy, or UAE)
Number of subjects: 179
Study: 35907513

Group type: EXPERIMENTAL
Intervention: Metformin 500mg by mouth three times a day for 30 to 36 months
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 34428506

Group type: EXPERIMENTAL
Intervention: Real-time reminders activated in rooms
Number of subjects: 111

Group type: COMPARATOR
Intervention: No real-time reminders activated in rooms
Number of subjects: 111
Study: 33011202

Group type: EXPERIMENTAL
Intervention: PAP communication device (SPEAX, Ataia Medical)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 36
Study: 32928570

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) associated with Stabilization Exercises (SE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group without Stabilization Exercises (SE)
Number of subjects: 40
Study: 35474569

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis (BL‐11) probiotic supplementation
Number of subjects: 36
Study: 34309668

Group type: EXPERIMENTAL
Intervention: Nontargeted screening
Number of subjects: 76561

Group type: EXPERIMENTAL
Intervention: Enhanced targeted screening
Number of subjects: 76561

Group type: EXPERIMENTAL
Intervention: Traditional targeted screening
Number of subjects: 76561

Group type: COMPARATOR
Intervention: Enhanced targeted and traditional targeted combined
Number of subjects: 76561

Group type: COMPARATOR
Intervention: Enhanced targeted only
Number of subjects: 76561
Study: 36282931

Group type: EXPERIMENTAL
Intervention: sotrovimab
Number of subjects: 1057

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1057
Study: 33820449

Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (5 sets × 5 repetitions maximum)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Moderate-intensity resistance training (2 sets × 25 repetitions maximum)
Number of subjects: 41
Study: 34303323

Group type: EXPERIMENTAL
Intervention: Jyoti-Trataka yoga (daily 55-min sessions for one month)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (administered oral hypoglycemic drugs only)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Between-group comparison post-treatment
Number of subjects: 60
Study: 33091807

Group type: EXPERIMENTAL
Intervention: tDCS over left PPC
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: tDCS over left IFG
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 51
Study: 35428352

Group type: EXPERIMENTAL
Intervention: COLORS training
Number of subjects: 5000

Group type: COMPARATOR
Intervention: General online LGBT cultural competency training
Number of subjects: 5000
Study: 34479668

Group type: EXPERIMENTAL
Intervention: 0.2% Chlorhexidine
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 1% Povidone-iodine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (distilled water)
Number of subjects: 61
Study: 32280080

Group type: EXPERIMENTAL
Intervention: Nimodipine combined with betahistine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Amlodipine (control group)
Number of subjects: 80
Study: 35559515

Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxia (IH, n=11)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Intermittent Normoxia (IN, n=6)
Number of subjects: 17
Study: 33899246

Group type: EXPERIMENTAL
Intervention: Sesame oil (SO)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Canola oil (CO)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Sesame-canola oil (SCO)
Number of subjects: 93
Study: 33332779

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg per kilogram of body weight intravenously)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 389
Study: 33075782

Group type: EXPERIMENTAL
Intervention: Lunch intervention
Number of subjects: 17

Group type: COMPARATOR
Intervention: Dinner intervention
Number of subjects: 17
Study: 36085179

Group type: EXPERIMENTAL
Intervention: Powered micro-saw
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional osteotome
Number of subjects: 60
Study: 32945218

Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg) plus myoinositol (4 g) per day
Number of subjects: 116

Group type: COMPARATOR
Intervention: Myoinositol (4 g) per day
Number of subjects: 116
Study: 35946404

Group type: EXPERIMENTAL
Intervention: Angiography+FFR
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Angiography
Number of subjects: 1100
Study: 33090016

Group type: EXPERIMENTAL
Intervention: Fast acting insulin aspart (FA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Insulin aspart (IAsp)
Number of subjects: 40
Study: 32623833

Group type: EXPERIMENTAL
Intervention: Micellar water, cream, and serum
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 34928336

Group type: EXPERIMENTAL
Intervention: Pooled Higher Doses (PHD) group (≥1 000 IU/day, n = 349)
Number of subjects: 688

Group type: COMPARATOR
Intervention: Control group (200 IU/day, n = 339)
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Pooled Higher Doses (PHD) group (≥1 000 IU/day)
Number of subjects: 688

Group type: COMPARATOR
Intervention: Control group (200 IU/day)
Number of subjects: 688
Study: 33902653

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (CHG) bathing intervention
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 14
Study: 35497400

Group type: EXPERIMENTAL
Intervention: Perceived breast cancer risk
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Younger participants
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: MRI utilization
Number of subjects: 339
Study: 32708828

Group type: EXPERIMENTAL
Intervention: Adherence to Mediterranean lifestyle (diet and exercise)
Number of subjects: 6355

Group type: EXPERIMENTAL
Intervention: Higher desired weight loss (Q4: ≥20%)
Number of subjects: 6355
Study: 32730089

Group type: EXPERIMENTAL
Intervention: Upper cervical spine manipulation (C1-C2)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Combination of cervical (C3-C4), cervicothoracic (C7-T1) and thoracic spine (T5-T6) thrust joint manipulation
Number of subjects: 186
Study: 33561663

Group type: EXPERIMENTAL
Intervention: VASobs
Number of subjects: 100
Study: 32721948

Group type: EXPERIMENTAL
Intervention: ZNF217 targeting with preexisting therapies, such as the Akt inhibitor triciribine
Number of subjects: 0

Group type: COMPARATOR
Intervention: High mammographic density
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collagen density and matrix stiffness
Number of subjects: 0
Study: 34223683

Group type: EXPERIMENTAL
Intervention: Usability testing of the proposed study method
Number of subjects: 0
Study: 32568205

Group type: EXPERIMENTAL
Intervention: Escitalopram (n=13; average dose=7.3 mg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Sertraline (n=11; average dose=31.8 mg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nicergoline (n=9; average dose=14.5 mg)
Number of subjects: 33
Study: 33723687

Group type: EXPERIMENTAL
Intervention: Vaginal fractional CO2 laser therapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Kegel exercise training
Number of subjects: 84
Study: 33774639

Group type: EXPERIMENTAL
Intervention: 1 g of collagen peptides (CP)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 5 g of collagen peptides (CP)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 34501582

Group type: EXPERIMENTAL
Intervention: Circuit resistance training (RT) program, 3 days/week for 12 weeks (n = 18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (n = 18)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Circuit resistance training (RT) program
Number of subjects: 36
Study: 32234463

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 318

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 318
Study: 32998038

Group type: EXPERIMENTAL
Intervention: COVID-19 positive patients
Number of subjects: 1054
Study: 33913736

Group type: EXPERIMENTAL
Intervention: Artesunate tablet (50 mg two times daily) combined with HAART
Number of subjects: 45

Group type: COMPARATOR
Intervention: HAART alone
Number of subjects: 45
Study: 35788775

Group type: EXPERIMENTAL
Intervention: Dietary advice to isocalorically increase protein intake to ≥ 1.2 g/kg aBW/d (Protein + ; n = 84)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control (n = 40)
Number of subjects: 124
Study: 35880828

Group type: EXPERIMENTAL
Intervention: Krill oil (4 g/d; 0.60 g EPA/d, 0.28 g DHA/d, 0.45 g astaxanthin/d)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo (mixed vegetable oil)
Number of subjects: 235
Study: 35263653

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 849

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: MCS (Mechanical Circulatory Support)
Number of subjects: 849

Group type: COMPARATOR
Intervention: No MCS
Number of subjects: 849
Study: 33612591

Group type: EXPERIMENTAL
Intervention: High Sugar Diet (HS) - 24% energy from sugar
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low Sugar Diet (LS) - 6% energy from sugar
Number of subjects: 25
Study: 35712946

Group type: EXPERIMENTAL
Intervention: Auricular bloodletting combined with auricular point sticking once a week for 4 weeks (treatment group 1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Auricular bloodletting combined with auricular point sticking twice a week for 4 weeks (treatment group 2)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Auricular bloodletting combined with auricular point sticking three times a week for 4 weeks (treatment group 3)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 90
Study: 33749948

Group type: EXPERIMENTAL
Intervention: Kitchen area concentrations of black carbon (BC)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Kitchen area concentrations of nitrogen dioxide (NO2)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Kitchen area concentrations of PM2.5
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Personal exposures to pollutants
Number of subjects: 180
Study: 32119886

Group type: EXPERIMENTAL
Intervention: Skin conductance level during sequence blocks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parietal EEG alpha and gamma power during sequence blocks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral performance (faster responses in sequence than in random blocks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: EEG parietal gamma power
Number of subjects: 0
Study: 35845983

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction
Number of subjects: 98

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 98
Study: 34505832

Group type: EXPERIMENTAL
Intervention: Empowered Relief (ER)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 104
Study: 33235314

Group type: EXPERIMENTAL
Intervention: Paclitaxel/carboplatin plus cetuximab (group B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Paclitaxel/carboplatin (group A)
Number of subjects: 150
Study: 33228772

Group type: EXPERIMENTAL
Intervention: Continuous enteral nutrition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittent enteral nutrition
Number of subjects: 0
Study: 35429820

Group type: EXPERIMENTAL
Intervention: CostCOM (n=32)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care (n=30)
Number of subjects: 62
Study: 33054640

Group type: EXPERIMENTAL
Intervention: Standing or sitting postures at work
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Medical examinations (in a subgroup of 100 people)
Number of subjects: 500
Study: 35693258

Group type: EXPERIMENTAL
Intervention: Ultrasound image-guided surgeries with an optimized image processing algorithm
Number of subjects: 60

Group type: COMPARATOR
Intervention: X-ray-guided foraminal microscope
Number of subjects: 60
Study: 32740716

Group type: EXPERIMENTAL
Intervention: Standard care with daily traditional experiential music listening
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard care only (Control Group)
Number of subjects: 79
Study: 33201130

Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression (IPC) in addition to standard prophylaxis with anti-embolic stockings and low-molecular-weight heparin
Number of subjects: 407

Group type: COMPARATOR
Intervention: Standard prophylaxis alone (control group)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression (IPC)
Number of subjects: 407
Study: 36308132

Group type: EXPERIMENTAL
Intervention: Phacoemulsification cataract surgery
Number of subjects: 310

Group type: COMPARATOR
Intervention: Manual small-incision cataract surgery (MSICS)
Number of subjects: 310
Study: 33970256

Group type: EXPERIMENTAL
Intervention: Depot buprenorphine (weekly or monthly)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Sublingual buprenorphine (daily)
Number of subjects: 119
Study: 32376759

Group type: EXPERIMENTAL
Intervention: Nasal fentanyl (NF) and buccal midazolam (BM) administered by family members
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buccal midazolam (BM) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard breakthrough medication by nurses
Number of subjects: 0
Study: 36460236

Group type: EXPERIMENTAL
Intervention: Silver Modified Atraumatic Restorative Treatment (SMART)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 67
Study: 34392656

Group type: EXPERIMENTAL
Intervention: Entecavir plus Ganshuang granule (GSG)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Entecavir plus placebo
Number of subjects: 135
Study: 32400089

Group type: EXPERIMENTAL
Intervention: Preoperative bed exercises and mobilization training
Number of subjects: 60
Study: 36351436

Group type: EXPERIMENTAL
Intervention: Genicular nerves block (20 ml ropivacaine 0.2%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Local infiltration analgesia (150 ml ropivacaine 0.2%)
Number of subjects: 60
Study: 33980467

Group type: EXPERIMENTAL
Intervention: Tivozanib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 0
Study: 35869721

Group type: EXPERIMENTAL
Intervention: Pulpotomy with CEM (205 cases)
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Pulpotomy with MTA (207 cases)
Number of subjects: 615

Group type: COMPARATOR
Intervention: Root canal therapy (RCT) (203 cases)
Number of subjects: 615
Study: 32725960

Group type: EXPERIMENTAL
Intervention: Real rTMS (HF-rTMS) during active cycling
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Real rTMS (HF-rTMS)
Number of subjects: 12
Study: 36109696

Group type: EXPERIMENTAL
Intervention: Preventive treatment based on botulinum toxin or oral drugs after 3 months
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (50 subjects)
Number of subjects: 46
Study: 32330764

Group type: EXPERIMENTAL
Intervention: VIT-based message (yes)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Physical harms emphasized (yes)
Number of subjects: 282
Study: 35379019

Group type: COMPARATOR
Intervention: Triamcinolone Hexacetonide (TH) 40 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline Solution (SS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 100